Generation of 3D Liver Microtissues from Induced Pluripotent Stem Cells

Area of Science:

• Regenerative Medicine
• Hepatology
• Biotechnology

Background:

• The liver's complex functions are vital for health, but damage leads to cirrhosis, with transplantation as the only cure.
• Current in vitro models and animal studies fail to replicate the intricate multicellular interactions crucial for liver homeostasis and disease.
• There is a critical need for advanced in vitro liver models that mimic native liver complexity for research and drug development.

Purpose of the Study:

• To establish a physiologically relevant three-dimensional (3D) microtissue platform that recapitulates human liver structure and function.
• To create a multicellular in vitro model using human-induced pluripotent stem cells (hiPSCs) for studying liver diseases.
• To develop a translationally relevant system for investigating liver pathogenesis, drug toxicity, and personalized therapeutics.

Main Methods:

• Differentiated hiPSCs into hepatocytes (Heps), hepatic stellate cells (HSCs), and liver sinusoidal endothelial cells (LSECs).
• Co-cultured these differentiated cells within a self-organizing 3D microenvironment to form a microtissue.
• Utilized the microtissue to model alcohol-induced steatogenesis and assess hepatic functionality.

Main Results:

• Successfully reconstructed a miniaturized, functional human liver microtissue model.
• The 3D microtissue demonstrated structural and functional characteristics mirroring the native liver.
• The model exhibited steatogenic responses to alcohol exposure, validating its utility for disease modeling.

Conclusions:

• The hiPSC-derived 3D microtissue platform provides a robust in vitro system for modeling human liver physiology and disease.
• This advanced model facilitates the study of intercellular signaling and fibrogenic pathways in chronic liver conditions.
• The platform offers significant potential for drug toxicity testing and the development of personalized therapeutic strategies for liver diseases.